{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:18:30Z","timestamp":1784204310819,"version":"3.55.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.hoc.2018.08.003","type":"journal-article","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T20:17:45Z","timestamp":1543263465000},"page":"121-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["A Review of Primary Cutaneous CD30+ Lymphoproliferative Disorders"],"prefix":"10.1016","volume":"33","author":[{"given":"Cynthia","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan D.","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa J.","family":"Geskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.hoc.2018.08.003_bib1","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hoc.2018.08.003_bib2","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/ijc.2910300411","article-title":"Identification of Hodgkin and Sternberg-reed cells as a unique cell type derived from a newly-detected small-cell population","volume":"30","author":"Stein","year":"1982","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/j.hoc.2018.08.003_bib3","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1006\/smim.1998.0156","article-title":"CD30: expression and function in health and disease","volume":"10","author":"Horie","year":"1998","journal-title":"Semin Immunol"},{"issue":"12","key":"10.1016\/j.hoc.2018.08.003_bib4","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1182\/blood.V95.12.3653","article-title":"Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment","volume":"95","author":"Bekkenk","year":"2000","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.hoc.2018.08.003_bib5","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/j.1600-0560.2007.00979.x","article-title":"Large CD30-positive cells in benign, atypical lymphoid infiltrates of the skin","volume":"35","author":"Werner","year":"2008","journal-title":"J\u00a0Cutan Pathol"},{"issue":"8","key":"10.1016\/j.hoc.2018.08.003_bib6","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1182\/blood.V83.8.2045.2045","article-title":"Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines","volume":"83","author":"Gruss","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2018.08.003_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1749-6632.2001.tb03711.x","article-title":"Progression of lymphomatoid papulosis to systemic lymphoma is associated with escape from growth inhibition by transforming growth factor-beta and CD30 ligand","volume":"941","author":"Kadin","year":"2001","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.hoc.2018.08.003_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/archderm.1968.01610070029004","article-title":"Lymphomatoid papulosis. A continuing self-healing eruption, clinically benign\u2013histologically malignant","volume":"97","author":"Macaulay","year":"1968","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.hoc.2018.08.003_bib9","first-page":"315","article-title":"Lymphomatoid papulosis. A cutaneous proliferation of activated helper T\u00a0cells expressing Hodgkin's disease-associated antigens","volume":"119","author":"Kadin","year":"1985","journal-title":"Am J Pathol"},{"issue":"9","key":"10.1016\/j.hoc.2018.08.003_bib10","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1182\/blood.V94.9.3077","article-title":"CD30-CD30 ligand interaction in primary cutaneous CD30(+) T-cell lymphomas: a clue to the pathophysiology of clinical regression","volume":"94","author":"Mori","year":"1999","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.hoc.2018.08.003_bib11","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1158\/1055-9965.EPI-04-0826","article-title":"Polymorphism of the CD30 promoter microsatellite repressive element is associated with development of primary cutaneous lymphoproliferative disorders","volume":"14","author":"Franchina","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"10.1016\/j.hoc.2018.08.003_bib12","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1684\/ejd.2015.2707","article-title":"Human T-cell leukemia virus type 1-positive lymphomatoid papulosis","volume":"26","author":"Namba","year":"2016","journal-title":"Eur J Dermatol"},{"issue":"6","key":"10.1016\/j.hoc.2018.08.003_bib13","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.jhep.2017.08.011","article-title":"Hepatitis E virus-induced primary cutaneous CD30(+) T\u00a0cell lymphoproliferative disorder","volume":"67","author":"Mallet","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.hoc.2018.08.003_bib14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/carcin\/24.2.301","article-title":"Endogenous retroviral elements, but not exogenous retroviruses, are detected in CD30-positive lymphoproliferative disorders of the skin","volume":"24","author":"Kempf","year":"2003","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.hoc.2018.08.003_bib15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1034\/j.1600-0560.2001.280103.x","article-title":"Lymphomatoid papulosis and human herpesviruses\u2013A PCR-based evaluation for the presence of human herpesvirus 6, 7 and 8 related herpesviruses","volume":"28","author":"Kempf","year":"2001","journal-title":"J\u00a0Cutan Pathol"},{"issue":"6","key":"10.1016\/j.hoc.2018.08.003_bib16","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.jaad.2012.12.972","article-title":"Investigation of molluscum contagiosum virus, orf and other parapoxviruses in lymphomatoid papulosis","volume":"68","author":"Fernandez","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.hoc.2018.08.003_bib17","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.hoc.2018.08.003_bib18","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.2217\/imt.11.113","article-title":"Chronic inflammation and immunologic-based constraints in malignant disease","volume":"3","author":"Lowe","year":"2011","journal-title":"Immunotherapy"},{"issue":"3","key":"10.1016\/j.hoc.2018.08.003_bib19","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00281-016-0594-9","article-title":"Malignant inflammation in cutaneous T-cell lymphoma-a hostile takeover","volume":"39","author":"Krejsgaard","year":"2017","journal-title":"Semin Immunopathol"},{"issue":"5","key":"10.1016\/j.hoc.2018.08.003_bib20","first-page":"E15","article-title":"Regional lymphomatoid papulosis of the breast restricted to an area of prior radiotherapy","volume":"97","author":"Haro","year":"2016","journal-title":"Cutis"},{"issue":"4","key":"10.1016\/j.hoc.2018.08.003_bib21","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0190-9622(08)80202-2","article-title":"Pustular lymphomatoid papulosis in childhood","volume":"27","author":"Barnadas","year":"1992","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.hoc.2018.08.003_bib22","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jaad.2012.12.952","article-title":"Follicular lymphomatoid papulosis revisited: a study of 11 cases, with new histopathological findings","volume":"68","author":"Kempf","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.hoc.2018.08.003_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000081485","article-title":"Oral involvement in lymphomatoid papulosis. Report of two cases and review of the literature","volume":"210","author":"Pujol","year":"2005","journal-title":"Dermatology"},{"issue":"6","key":"10.1016\/j.hoc.2018.08.003_bib24","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1046\/j.1365-2133.1999.03218.x","article-title":"Regional lymphomatoid papulosis: a report of four cases","volume":"141","author":"Scarisbrick","year":"1999","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.hoc.2018.08.003_bib25","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.jaad.2007.05.046","article-title":"Persistent agmination of lymphomatoid papulosis: an equivalent of limited plaque mycosis fungoides type of cutaneous T-cell lymphoma","volume":"57","author":"Heald","year":"2007","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.hoc.2018.08.003_bib26","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/archderm.140.3.306","article-title":"Lymphomatoid papulosis in children: a retrospective cohort study of 35 cases","volume":"140","author":"Nijsten","year":"2004","journal-title":"Arch Dermatol"},{"issue":"20","key":"10.1016\/j.hoc.2018.08.003_bib27","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.hoc.2018.08.003_bib28","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1309\/73DBA1EPAWF6F1T0","article-title":"Granulomatous eccrinotropic lymphomatoid papulosis","volume":"119","author":"Crowson","year":"2003","journal-title":"Am J Clin Pathol"},{"issue":"11","key":"10.1016\/j.hoc.2018.08.003_bib29","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1097\/PAS.0000000000000474","article-title":"Intralymphatic spread is a common finding in cutaneous CD30+ lymphoproliferative disorders","volume":"39","author":"Ferrara","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.hoc.2018.08.003_bib30","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/cup.12773","article-title":"CD30+ lymphoproliferative disorder with spindle-cell morphology","volume":"43","author":"Martires","year":"2016","journal-title":"J\u00a0Cutan Pathol"},{"issue":"2","key":"10.1016\/j.hoc.2018.08.003_bib31","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1182\/blood-2001-12-0199","article-title":"Single-cell analysis of CD30+ cells in lymphomatoid papulosis demonstrates a common clonal T-cell origin","volume":"100","author":"Steinhoff","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2018.08.003_bib32","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jaad.2005.01.014","article-title":"T-cell clonality of peripheral blood lymphocytes in patients with lymphomatoid papulosis","volume":"53","author":"Schultz","year":"2005","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.hoc.2018.08.003_bib33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/jid.2008.204","article-title":"Dominance of nonmalignant T-cell clones and distortion of the TCR repertoire in the peripheral blood of patients with cutaneous CD30+ lymphoproliferative disorders","volume":"129","author":"Humme","year":"2009","journal-title":"J\u00a0Invest Dermatol"},{"issue":"1","key":"10.1016\/j.hoc.2018.08.003_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PAS.0b013e3182648596","article-title":"Angioinvasive lymphomatoid papulosis: a new variant simulating aggressive lymphomas","volume":"37","author":"Kempf","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.hoc.2018.08.003_bib35","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaad.2015.09.013","article-title":"Lymphomatoid papulosis: treatment response and associated lymphomas in a study of 180 patients","volume":"74","author":"Wieser","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"15","key":"10.1016\/j.hoc.2018.08.003_bib36","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1182\/blood-2011-05-351346","article-title":"EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma","volume":"118","author":"Kempf","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.hoc.2018.08.003_bib37","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0190-9622(96)90442-9","article-title":"Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders","volume":"34","author":"Vonderheid","year":"1996","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.hoc.2018.08.003_bib38","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/bjd.13920","article-title":"Recommendations for treatment of lymphomatoid papulosis with methotrexate: a report from the Dutch Cutaneous Lymphoma Group","volume":"173","author":"Bruijn","year":"2015","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.hoc.2018.08.003_bib39","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.jaad.2015.03.001","article-title":"The efficacy of methotrexate for lymphomatoid papulosis","volume":"72","author":"Newland","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"32","key":"10.1016\/j.hoc.2018.08.003_bib40","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1200\/JCO.2014.60.3787","article-title":"Results of a phase II trial of brentuximab vedotin for CD30+ cutaneous T-cell lymphoma and lymphomatoid papulosis","volume":"33","author":"Duvic","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.hoc.2018.08.003_bib41","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000068451","article-title":"Bexarotene is a new treatment option for lymphomatoid papulosis","volume":"206","author":"Krathen","year":"2003","journal-title":"Dermatology"},{"issue":"2","key":"10.1016\/j.hoc.2018.08.003_bib42","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1111\/1346-8138.14095","article-title":"Successful control of phototherapy-resistant lymphomatoid papulosis with oral bexarotene","volume":"45","author":"Fujimura","year":"2018","journal-title":"J\u00a0Dermatol"},{"issue":"11","key":"10.1016\/j.hoc.2018.08.003_bib43","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1001\/archderm.1985.01660110058016","article-title":"Topical carmustine therapy for lymphomatoid papulosis","volume":"121","author":"Zackheim","year":"1985","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.hoc.2018.08.003_bib44","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1440-0960.2008.00505.x","article-title":"Successful treatment of lymphomatoid papulosis with photodynamic therapy","volume":"50","author":"Rodrigues","year":"2009","journal-title":"Australas J Dermatol"},{"issue":"6","key":"10.1016\/j.hoc.2018.08.003_bib45","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0190-9622(03)02484-8","article-title":"CD30+ cutaneous lymphoproliferative disorders: the Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma","volume":"49","author":"Liu","year":"2003","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.hoc.2018.08.003_bib46","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1365-2230.2008.03024.x","article-title":"Lymphomatoid papulosis and associated lymphomas: a retrospective case series of 84 patients","volume":"34","author":"Kunishige","year":"2009","journal-title":"Clin Exp Dermatol"},{"issue":"17","key":"10.1016\/j.hoc.2018.08.003_bib47","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1056\/NEJM199204233261704","article-title":"Hodgkin's disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone","volume":"326","author":"Davis","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.hoc.2018.08.003_bib48","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1067\/S0190-9622(03)01577-9","article-title":"Lymphomatoid papulosis associated with mycosis fungoides: a study of 21 patients including analyses for clonality","volume":"49","author":"Zackheim","year":"2003","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.hoc.2018.08.003_bib49","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1182\/blood.V66.4.848.848","article-title":"The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells","volume":"66","author":"Stein","year":"1985","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hoc.2018.08.003_bib50","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/hon.897","article-title":"Anaplastic large cell lymphoma: one or more entities among T-cell lymphoma?","volume":"27","author":"Fornari","year":"2009","journal-title":"Hematol Oncol"},{"issue":"3","key":"10.1016\/j.hoc.2018.08.003_bib51","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0037-1963(03)00138-0","article-title":"Systemic and primary cutaneous anaplastic large cell lymphomas","volume":"40","author":"Kadin","year":"2003","journal-title":"Semin Hematol"},{"issue":"6","key":"10.1016\/j.hoc.2018.08.003_bib52","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1001\/archdermatol.2009.74","article-title":"Prognostic factors in primary cutaneous anaplastic large cell lymphoma: characterization of clinical subset with worse outcome","volume":"145","author":"Woo","year":"2009","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.hoc.2018.08.003_bib53","first-page":"331","article-title":"Clinical spectrum of primary cutaneous CD30-positive anaplastic large cell lymphoma: an analysis of the Mannheim Cutaneous Lymphoma Registry","volume":"10","author":"Booken","year":"2012","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"issue":"3","key":"10.1016\/j.hoc.2018.08.003_bib54","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1046\/j.1365-2133.2003.05248.x","article-title":"Pyogenic lymphoma of the skin: a peculiar variant of primary cutaneous neutrophil-rich CD30+ anaplastic large-cell lymphoma. Clinicopathological study of four cases and review of the literature","volume":"148","author":"Burg","year":"2003","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.hoc.2018.08.003_bib55","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1600-0560.2007.00778.x","article-title":"The morphologic spectrum of primary cutaneous anaplastic large T-cell lymphoma: a histopathologic study on 66 biopsy specimens from 47 patients with report of rare variants","volume":"35","author":"Massone","year":"2008","journal-title":"J\u00a0Cutan Pathol"},{"issue":"1","key":"10.1016\/j.hoc.2018.08.003_bib56","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3324\/haematol.2012.065664","article-title":"ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study","volume":"98","author":"Oschlies","year":"2013","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.hoc.2018.08.003_bib57","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/ajcp\/105.4.440","article-title":"CD30-positive cutaneous large cell lymphomas. A comparative study of clinicopathologic and molecular features of 16 cases","volume":"105","author":"Macgrogan","year":"1996","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.hoc.2018.08.003_bib58","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/jid.2009.314","article-title":"IRF4 gene rearrangements define a subgroup of CD30-positive cutaneous T-cell lymphoma: a study of 54 cases","volume":"130","author":"Pham-Ledard","year":"2010","journal-title":"J\u00a0Invest Dermatol"},{"issue":"5","key":"10.1016\/j.hoc.2018.08.003_bib59","first-page":"1148","article-title":"Bone marrow examination has limited value in the staging of patients with an anaplastic large cell lymphoma first presenting in the skin. Retrospective analysis of 107 patients","volume":"159","author":"Benner","year":"2008","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.hoc.2018.08.003_bib60","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1182\/blood-2006-10-054601","volume":"110","author":"Kim","year":"2007","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.hoc.2018.08.003_bib61","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/archdermatol.2009.280","article-title":"Applicability and prognostic value of the new TNM classification system in 135 patients with primary cutaneous anaplastic large cell lymphoma","volume":"145","author":"Benner","year":"2009","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.hoc.2018.08.003_bib62","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1002\/1097-0142(19930315)71:6<2097::AID-CNCR2820710626>3.0.CO;2-7","article-title":"Primary cutaneous CD30-positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis. A European Multicenter Study of 47 patients","volume":"71","author":"Beljaards","year":"1993","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.hoc.2018.08.003_bib63","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1200\/JCO.1995.13.6.1343","article-title":"CD30\/Ki-1-positive lymphoproliferative disorders of the skin\u2013clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group","volume":"13","author":"Paulli","year":"1995","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.hoc.2018.08.003_bib64","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1080\/10428190903045385","article-title":"Sustained response of primary cutaneous CD30 positive anaplastic large cell lymphoma to bexarotene and photopheresis","volume":"50","author":"Sheehy","year":"2009","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"10.1016\/j.hoc.2018.08.003_bib65","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1016\/j.leukres.2011.06.029","article-title":"Primary cutaneous CD30 positive anaplastic large cell lymphoma\u2013report of a case treated with bexarotene","volume":"35","author":"Oliveira","year":"2011","journal-title":"Leuk Res"},{"issue":"10094","key":"10.1016\/j.hoc.2018.08.003_bib66","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0140-6736(17)31266-7","article-title":"Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial","volume":"390","author":"Prince","year":"2017","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.hoc.2018.08.003_bib67","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1067\/mjd.2001.117519","article-title":"Regression of multifocal, skin-restricted, CD30-positive large T-cell lymphoma with interferon alfa and bexarotene therapy","volume":"45","author":"French","year":"2001","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.hoc.2018.08.003_bib68","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jaad.2003.10.669","article-title":"Low-dose oral bexarotene in combination with low-dose interferon alfa in the treatment of cutaneous T-cell lymphoma: clinical synergism and possible immunologic mechanisms","volume":"50","author":"McGinnis","year":"2004","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.hoc.2018.08.003_bib69","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1365-2133.2009.09042.x","article-title":"Multifocal primary cutaneous CD30+ anaplastic large cell lymphoma responsive to thalidomide: the molecular mechanism and the clinical application","volume":"160","author":"Lee","year":"2009","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.hoc.2018.08.003_bib70","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3816\/CLM.2006.n.039","article-title":"Phase II evaluation of gemcitabine monotherapy for cutaneous T-cell lymphoma","volume":"7","author":"Duvic","year":"2006","journal-title":"Clin Lymphoma Myeloma"},{"issue":"5","key":"10.1016\/j.hoc.2018.08.003_bib71","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1365-2133.1992.tb14853.x","article-title":"Oral etoposide in the treatment of cutaneous large-cell lymphomas. A preliminary report of four cases","volume":"127","author":"Rijlaarsdam","year":"1992","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.hoc.2018.08.003_bib72","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1111\/ajt.12281","article-title":"Primary cutaneous posttransplant lymphoproliferative disorders in solid organ transplant recipients: a multicenter European case series","volume":"13","author":"Seckin","year":"2013","journal-title":"Am J Transplant"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858818307810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858818307810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:10:29Z","timestamp":1760184629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858818307810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0889858818307810"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2018.08.003","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Review of Primary Cutaneous CD30+ Lymphoproliferative Disorders","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2018.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}